Tu, Ang A. http://orcid.org/0000-0001-5145-7869
Gierahn, Todd M.
Monian, Brinda
Morgan, Duncan M. http://orcid.org/0000-0002-3253-1362
Mehta, Naveen K.
Ruiter, Bert
Shreffler, Wayne G.
Shalek, Alex K. http://orcid.org/0000-0001-5670-8778
Love, J. Christopher http://orcid.org/0000-0003-0921-3144
Funding for this research was provided by:
Broad Institute
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI095261, 5P01AI039671, 5U19AI089992, U19AI095261, 5P01AI039671, U19AI095261, 5P01AI039671)
Koch Institute - Dana-Farber/Harvard Cancer Center Bridge Project.
U.S. Department of Health & Human Services | National Institutes of Health (1U54CA217377, 2RM1HG006193, 1R33CA202820, 1R01AI138546, 1R01DA046277, 1U2CCA23319501)
Searle Scholars Program, Beckman Young Investigator Program,Pew-Stewart Scholars Program for Cancer Research
Article History
Received: 26 March 2019
Accepted: 21 October 2019
First Online: 19 November 2019
Competing interests
: A.A.T., T.M.G., J.C.L. and the Massachusetts Institute of Technology have filed a patent application (patent no. PCT/US2018/013443) that relates to T cell receptor recovery, compositions of matter and the outlined experimental and computational methods and uses thereof. J.C.L. and A.K.S. are co-founders and shareholders of Honeycomb Biotechnologies, Inc. T.M.G. is currently an employee of Honeycomb Biotechnologies, Inc.